This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (86451)
-
October 30, 2025 | Insight Novo Nordisk dodges antitrust law in swoop for Metsera, Pfizer says
Sections: DealRisk® and Mergers and Acquisitions
-
October 30, 2025 | Official Statement Metsera calls Novo Nordisk $9.1bn proposal 'Superior'
Sections: DealRisk® and Mergers and Acquisitions
-
October 30, 2025 | Press Round-Up United States Antitrust Press Round-Up United States | 30 Oct 2025
Sections: Antitrust and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login